SS

Suhas Shriram Bavikar

Active Director Designated Partner DIN 11242650
DIN 11242650 First appointment Aug 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Suhas Shriram Bavikar

Data last updated:

Suhas Shriram Bavikar is a Designated Partner at Utkarsh Hospital & Dialysis Centre Llp (since 2025).

DIN 11242650
Primary Designation Designated Partner
First Appointment 14 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner14 Aug 20252025Active

Board colleagues of Suhas Shriram Bavikar

Directorship timeline

Open interactive timeline →
Utkarsh Hospital & Dialysis Centre Llp
Premium access

Shareholding and investment profile for Suhas Shriram Bavikar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suhas Shriram Bavikar

Suhas Shriram Bavikar currently holds 1 directorship: Utkarsh Hospital & Dialysis Centre Llp (Designated Partner, since 14 Aug 2025).

Suhas Shriram Bavikar was first appointed on 14 Aug 2025 as Designated Partner at Utkarsh Hospital & Dialysis Centre Llp.

The current boards of Suhas Shriram Bavikar's companies include Gaurav Suresh Nijhon (Utkarsh Hospital & Dialysis Centre Llp), Jaysree Suhas Bavikar (Utkarsh Hospital & Dialysis Centre Llp), Prajakta Suhas Bavikar (Utkarsh Hospital & Dialysis Centre Llp), Purva Suhas Bavikar (Utkarsh Hospital & Dialysis Centre Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available